June 7-8, 2022
Online Livestream
Diversity in ClinicalTrials
Revolutionize Trial Outcomes through Improved Diversity Outreach and Representation


Days
Hours
Minutes
Seconds

The COVID-19 pandemic has brought health disparities into the spotlight and further highlighted the stark differences in trial demographics. Before the healthcare disparity problem grows even worse, now is the time to re-center drug development around patient diversity, and ensure clinical trials are inclusive of the populations that will ultimately use these therapies.

There has never been a more critical time than now for the biopharma industries to work collaboratively with stakeholders to ensure studies represent the intended patient population likely to use a medicine once approved. This June 7-8, join us at the Diversity in Clinical Trials Summit to make a positive impact on drug innovation and development, disease awareness, clinical trial outcomes, and health equity.

Top Reasons to Attend
  • Utilize RWE And RWD To Close The Diversity Gaps
  • Build Trust And Establish Long Term Relationships With External Partners
  • Work With Trial Sites To Attain Diversity, Inclusion, And Health Equity In Clinical Trials
  • Understand How Decentralized Trials Can Improve Diverse Representation In Clinical Studies
  • Hear The Importance Of Applying DE&I Across The Industry In The Early Development Phase For Clinical Trials
  • Ensure Diverse And Inclusive Enrollment In Clinical Trials Through Close Collaboration
  • Improve Health Equity and Generate Evidence To Achieve Better Patient Outcomes
  • Address The Impact Of The Clinical Treatment Act On Minority Enrollment
  • Understand Health Literacy For Clinical Research Enrollment
  • Increase Diversity Among Principal Investigators and The Clinical Trial Community
Who Should Attend

This conference is designed for pharmaceutical, biotech, and medical device professionals responsible for:

  • Diversity & Inclusion
  • Clinical Operations
  • Patient Centricity
  • Clinical Research
  • Clinical Development
  • Patient Experience
  • Patient Centric Drug Development
  • Patient Engagement
  • Patient Experience
  • Patient Affairs and Advocacy
  • Public Affairs/Policy
  • Medical Science Liaison
  • KOL
  • Health Outcomes
  • Patient Recruitment
  • Clinical Technology
  • Clinical Affairs
  • Clinical Data Management
  • Site Manager
  • Medical Director
  • Research & Development
  • Clinical Trial Design
  • HEOR
  • RWD
  • Clinical Research Scientist
  • Principal Investigators
  • Site Feasibility
  • Clinical Trials Management
  • Medical Affairs
  • Medical Communications
  • Chief Medical Officers
  • Patient Experience/Access
  • Chief Patient Officers
  • Study Endpoint Development
  • Patient Communications
  • Patient Affairs & Engagement

This Program Is Also Of Interest To:

  • Diversity Consultants
  • Patient Recruitment Providers
  • Clinical Trial / Research Site
  • Clinical Trial Suppliers
  • Universities with Health Systems
  • Cancer Research Centers
  • CROs
Event Sponsors
Conference
New Topics
Event Association Partners
Event Partners






 

15
Speakers
21
Days
251
Participants
125
Workshops
90
Venue
Contact Us